Last Updated: September, 2024
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing an Osimertinib Mesylate production plant. It encompasses all critical aspects necessary for Osimertinib Mesylate production, including the cost of Osimertinib Mesylate production, Osimertinib Mesylate plant cost, Osimertinib Mesylate production costs, and the overall Osimertinib Mesylate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Osimertinib Mesylate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Osimertinib Mesylate is an FDA-approved third-generation oral drug known for its potential antineoplastic activity. It is widely used for the treatment of cancer, particularly non-small cell lung cancer (NSCLC). Moreover, it also finds its application for the treatment of EGFRT790M mutation-positive non-small cell lung cancer. Additionally, it is often employed in the treatment of advanced NSCLC, especially in patients whose tumors have developed resistance to earlier generations of EGFR inhibitors.
The demand for Osimertinib Mesylate is primarily driven by its role as an antineoplastic agent for the treatment of non-small cell lung cancer (NSCLC), with specific mutations in the EGFR (epidermal growth factor receptor), which significantly boosts its market expansion. Moreover, it mainly finds its employment as a drug in targeted cancer therapy, further enhancing its demand in the medical and pharmaceutical industries. Additionally, its employment in the medical industry, the availability and cost of raw materials like N-Methylindole, etc. regulatory compliance, quality standards, supplier relationships, efficient distribution, and logistics are certain crucial factors that globally influence industrial Osimertinib Mesylate procurement.
According to the Osimertinib Mesylate production plant project report, the major raw materials for Osimertinib Mesylate production include N-Methylindole and Dichloropyrimidine.
The extensive Osimertinib Mesylate production cost report consists of the following industrial production process:
Osimertinib Mesylate is an orally available compound that is the mesylate salt form of Osimertinib. The molecular formula of the compound is C29H37N7O5S, and its molecular weight is 595.72 g/mol. It is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug. Moreover, the melting point of the compound is >232°C, and it is stored frozen at -20°C under an inert atmosphere. It exists in the form of a yellowish-white solid that is slightly soluble in DMSO and Methanol. Additionally, the oral bioavailability of the drug is around 70%.
Osimertinib Mesylate Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Osimertinib Mesylate |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Osimertinib Mesylate but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Osimertinib Mesylate market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Vishakha Agrawal
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
